HomeCERS • NASDAQ
add
Cerus Corp
Previous close
$1.65
Day range
$1.52 - $1.67
Year range
$1.38 - $2.59
Market cap
284.14M USD
Avg Volume
1.43M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 50.81M | 8.64% |
Operating expense | 28.83M | 15.41% |
Net income | -2.52M | -89.83% |
Net profit margin | -4.96 | -74.65% |
Earnings per share | -0.01 | 0.00% |
EBITDA | -1.12M | -168.82% |
Effective tax rate | -4.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.45M | 22.17% |
Total assets | 200.92M | 1.60% |
Total liabilities | 144.02M | -0.20% |
Total equity | 56.90M | — |
Shares outstanding | 185.79M | — |
Price to book | 5.50 | — |
Return on assets | -1.86% | — |
Return on capital | -2.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.52M | -89.83% |
Cash from operations | 4.93M | 132.46% |
Cash from investing | -7.29M | -188.68% |
Cash from financing | 746.00K | -36.94% |
Net change in cash | -1.85M | 68.14% |
Free cash flow | 4.62M | 129.07% |
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
622
